sprite-preloader
Anzeige
Mehr »
Sonntag, 17.12.2017 Börsentäglich über 12.000 News von 575 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: 898243 ISIN: US6994621075 Ticker-Symbol: N/A 
Aktie:
Branche
Gesundheitswesen
Aktienmarkt
nicht mehr börsennotiert
1-Jahres-Chart
PAREXEL INTERNATIONAL CORPORATION Chart 1 Jahr
1-Woche-Intraday-Chart
PAREXEL INTERNATIONAL CORPORATION 1-Woche-Intraday-Chart
07.12.2017 | 18:46
(7 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

DUBLIN, Dec. 7, 2017 /PRNewswire/ --

The "Global Pharmaceutical Drug Development Services - Procurement Market Intelligence Report" report has been added to Research and Markets' offering.

Research and Markets Logo

Global Pharmaceutical Drug Development Services Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

The demand for drug development services comes from pharmaceutical and biotechnology companies. This is mainly because these companies are increasingly outsourcing drug development services to CROs to reduce drug development cost. Additionally, lead identification, drug discovery, clinical trial monitoring, and regulatory compliance are the services that will drive the growth of the global pharmaceutical drug development services market.

One of the procurement best practices for buyers in the global pharmaceutical drug development services market is to collaborate with local CROs if project size is small. There is a trend of long-term strategic partnerships in the industry, and as a result, global CROs allocate their best resources to these strategic alliances.

According to the report, one of the key growth drivers for the global pharmaceutical drug development services market is the high demand for drug development services from pharmaceutical and biotechnology companies. This is mainly because these companies are increasingly outsourcing drug development services to CROs to reduce drug development costs amid increasing regulatory stringency and reimbursements.

Further, the report states that one of the key procurement challenges faced by buyers is the issues in data integration and management. Data integration is a pressing issue for buyers as CROs often use disparate sources and formats that might not be compatible with their systems.

Key Topics Covered:

PART 1: CATEGORY AT A GLANCE

PART 2: SCOPE OF THE REPORT

PART 3: MARKET INSIGHTS

  • Category Spend Analysis
  • Category Maturity by Regions
  • Demand-Supply Shifts
  • Regional Demand-Supply Snapshot
  • Global Molasses Production Hubs
  • Market Developments
  • Regional Impact of Trends
  • Key Category Growth Drivers and Corresponding Regional Impacts
  • Major Category Growth Constraints and Corresponding Regional Impacts
  • Key Current Technological Innovations
  • Major Regulatory Frameworks
  • Strategic Sustainability Practices
  • Porter's Five Forces
  • PESTLE Analysis

PART 4: SUPPLY MARKET INSIGHTS

  • Supplier Operational Capability Matrix
  • Other Prominent Suppliers by Region: Operational Capability Matrix
  • Supplier Functional Capability Matrix
  • Other Prominent Suppliers by Region: Functional Capability Matrix
  • Key Clients/Partners
  • Supplier Cost Breakup
  • Supplier Positioning Matrix

PART 5: PRICING INSIGHTS

  • Pricing Models Snapshot
  • Pricing Models - Pros and Cons
  • Indicative Pricing

PART 6: PROCUREMENT INSIGHTS

  • Major Category Requirements
  • Major Procurement Pain Points
  • Category Sourcing Evolution Matrix
  • Procurement Best Practices
  • Cost-saving Opportunities
  • Supplier Selection Criteria
  • Category Negotiation Strategies
  • SLA Terms
  • Supplier Evaluation Criteria
  • Category Risk Analysis

PART 7: TOP FIVE SUPPLIERS

  • IQVIA
  • LabCorp
  • PAREXEL
  • ICON
  • INC Research

For more information about this report visit https://www.researchandmarkets.com/research/9tk2sf/global?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716




© 2017 PR Newswire